NCT02777151View on ClinicalTrials.gov

Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 27, 2016

Primary Completion Date

April 26, 2017

Study Completion Date

April 26, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

REGN3470-3471-3479

DRUG

Placebo

Trial Locations (1)

Unknown

Evansville

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT02777151 - Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter